Trial Profile
Duloxetine [Cymbalta; Eli Lilly] 60/120mg versus placebo in the treatment of fibromyalgia syndrome.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Sep 2021
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Fibromyalgia
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company (India) Pvt. Ltd
- 16 Jun 2008 US FDA approves duloxetine for the management of fibromyalgia according to Eli Lilly media release.
- 22 Aug 2007 Results have been reported.
- 22 Aug 2007 Status changed from in progress to completed.